New Zealand markets closed

NeuroMetrix, Inc. (NURO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.34-1.01 (-12.10%)
At close: 4:00PM EDT
7.23 -0.11 (-1.50%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.35
Bid7.22 x 2200
Ask7.29 x 1000
Day's range7.15 - 8.11
52-week range1.47 - 38.75
Avg. volume3,718,668
Market cap48.777M
Beta (5Y monthly)3.08
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date28 Mar 2007
1y target estN/A
  • GlobeNewswire

    NeuroMetrix Reports Q3 2021 Financial Results

    WOBURN, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Highlights: Revenue of $2.1 million was up slightly from Q3 2020. Gross margin on revenue was $1.4 million, a 70.0% gross margin rate. This was a decrease of 3.6 percentage points from $1.5 m

  • GlobeNewswire

    NeuroMetrix Names Strategic Growth Executive, Susan M. Bell, RN, BN, as Senior Vice President of Population Health & Value Based Care

    WOBURN, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Susan M. Bell as Senior Vice President, Population Health & Value Based Care. Ms. Bell will be responsible for growing the Company's DPNCheck® business with a primary focus on the Medicare Advantage population, and more broadly, expanding the Company's footprint in the value-based healthcare market. DPNCheck is a widely used point-of-care test that provides physicians with fast

  • GlobeNewswire

    NeuroMetrix, Inc. Announces Date for Third Quarter 2021 Financial Results Conference Call

    WOBURN, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 third quarter financial results before the opening of the market on October 21, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on October 21, 2021 to discuss its financial results as well as business developments affecting the Company. The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation